Filtros de búsqueda

Lista de obras de

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

artículo científico publicado el 29 de diciembre de 2011

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

artículo científico publicado en 2014

A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway.

artículo científico publicado en 2017

Alopecia as surrogate marker for chemotherapy response in patients with primary epithelial ovarian cancer: a metaanalysis of four prospective randomised phase III trials with 5114 patients

artículo científico publicado en 2015

Apolipoprotein E is required for cell proliferation and survival in ovarian cancer.

artículo científico publicado en 2005

Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis

artículo científico publicado en 2020

Beta-catenin expression in uterine sarcomas and its relation to clinicopathological parameters

artículo científico publicado en 2009

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial

artículo científico publicado en 2014

Caveolin-1 expression in ovarian carcinoma is MDR1 independent

artículo científico publicado en 2002

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).

artículo científico publicado en 2017

Chromatin organisation and cancer prognosis: a pan-cancer study

artículo científico publicado en 2018

Clinical Outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy Only

artículo científico publicado en 2018

Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity

artículo científico publicado en 2020

Cyclins and proliferation markers in early squamous cervical carcinoma

artículo científico publicado en 2004

DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses

artículo científico publicado en 2020

DCE-MRI-Derived Measures of Tumor Hypoxia and Interstitial Fluid Pressure Predict Outcomes in Cervical Carcinoma

artículo científico publicado en 2018

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

artículo científico publicado en 2011

Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers

artículo científico publicado en 2011

Diagnosis and treatment of sarcoma of the uterus. A review

artículo científico publicado el 1 de julio de 2012

Dynamic Contrast-Enhanced MRI of Cervical Cancers: Temporal Percentile Screening of Contrast Enhancement Identifies Parameters for Prediction of Chemoradioresistance

artículo científico publicado el 17 de octubre de 2011

E-cadherin and catenins in early squamous cervical carcinoma

artículo científico publicado en 2004

EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

artículo científico publicado el 1 de enero de 2003

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

artículo científico publicado en 2010

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma

artículo científico publicado en 2004

Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial.

artículo científico publicado en 2016

Egenskaper ved kreftcellenes DNA påvirker prognosen

artículo científico publicado en 2017

Endometrial cancer: the management of high-risk disease

artículo científico publicado en 2004

Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas

artículo científico publicado en 2014

European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies

artículo científico publicado en 2010

Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients.

artículo científico publicado en 2017

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO).

artículo científico publicado en 2014

Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer

artículo científico publicado en 2018

Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care

artículo científico publicado en 2020

Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome

artículo científico publicado en 2009

Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis

artículo científico publicado el 1 de abril de 2003

Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma

artículo científico publicado en 2003

Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma

artículo científico publicado en 2005

Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis

artículo científico publicado en 2008

First-line therapy in ovarian cancer trials.

artículo científico publicado en 2011

Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer

artículo científico publicado en 2009

Gene expression patterns in ovarian carcinomas

artículo científico publicado en 2003

Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers

artículo científico publicado en 2006

Gene expression signatures of primary and metastatic uterine leiomyosarcoma

artículo científico publicado en 2013

Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer

artículo científico publicado en 2006

GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data

artículo científico publicado en 2008

Genome profiles of bilateral dysgerminomas, a unilateral gonadoblastoma, and a metastasis from a 46, XY phenotypic female

artículo científico publicado el 1 de septiembre de 2003

Genomic aberrations in carcinomas of the uterine corpus

scientific article published on 01 July 2004

Genomic imbalances in endometrial adenocarcinomas — Comparison of DNA ploidy, karyotyping and comparative genomic hybridization

artículo científico publicado el 20 de octubre de 2011

Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma

artículo científico publicado en 2004

Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.

artículo científico publicado en 2014

High levels of genomic aberrations in serous ovarian cancers are associated with better survival

artículo científico publicado en 2013

High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection

artículo científico publicado en 2006

High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas

artículo científico publicado en 2005

Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma

artículo científico publicado en 2008

Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma

artículo científico publicado en 2008

Hypoxia-Induced Gene Expression in Chemoradioresistant Cervical Cancer Revealed by Dynamic Contrast-Enhanced MRI

artículo científico publicado el 13 de agosto de 2012

Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients

artículo científico publicado en 2016

Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling

artículo científico

Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes

artículo científico publicado en 2019

Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer

artículo científico publicado en 2016

Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions

artículo científico publicado en 2002

Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer

artículo científico publicado en 2015

Intestinal malabsorption in long-term survivors of cervical cancer treated with radiotherapy

artículo científico publicado en 2008

Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix

artículo científico publicado en 2004

L1CAM as a prognostic marker in stage I endometrial cancer: a validation study.

artículo científico publicado en 2016

Late effects after radiotherapy for locally advanced cervical cancer: comparison of two brachytherapy schedules and effect of dose delivered weekly

artículo científico publicado en 2009

Long-term outcomes after pelvic radiation for early-stage endometrial cancer

scientific article published on 09 September 2013

Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis

artículo científico publicado en 2009

MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

artículo científico publicado en 2020

MR Imaging Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer

scientific article published on 30 June 2020

Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.

artículo científico publicado en 2011

Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas

artículo científico publicado en 2007

Microsatellite instability in cervical and endometrial carcinomas

artículo científico publicado en 1997

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

artículo científico publicado en 2023

Multinational study exploring patients' perceptions of side-effects induced by chemo-radiotherapy

artículo científico publicado en 2015

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

artículo científico publicado en 2010

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

artículo científico publicado en 2018

Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase

artículo científico publicado en 2016

PIK3CA mutations in advanced ovarian carcinomas

artículo científico publicado en 2005

Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse

artículo científico publicado en 2010

Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma

artículo científico publicado en 2014

Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers

artículo científico publicado el 1 de agosto de 2011

Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model

scientific article published on 27 February 2019

Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome

artículo científico publicado el 17 de enero de 2013

Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer

artículo científico publicado el 23 de agosto de 2010

Phosphorylation of EGFR measured with in situ proximity ligation assay: Relationship to EGFR protein level and gene dosage in cervical cancer

artículo científico publicado el 15 de junio de 2011

Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?

artículo científico publicado en 2008

Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas

artículo científico publicado en 2006

Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer

artículo científico publicado en 2017

Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer

artículo científico publicado el 1 de septiembre de 2011

Prognostic Value of the Diversity of Nuclear Chromatin Compartments in Gynaecological Carcinomas

scientific article published on 19 December 2020

Prognostic significance of dysadherin expression in cervical squamous cell carcinoma

artículo científico publicado en 2004

Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma

artículo científico publicado en 2004

Protein Expression and Prognostic Value of Genes in the erb-b Signaling Pathway in Advanced Ovarian Carcinomas

article

Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas

scientific article published on 01 September 2005

Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling

artículo científico

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy

artículo científico publicado en 2013

Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial

artículo científico publicado en 2010

Risk grouping in stage IB squamous cell cervical carcinoma

artículo científico publicado en 2005

Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial.

artículo científico publicado en 2016

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies

artículo científico publicado en 2010

Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer

artículo científico publicado en 2015

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

artículo científico publicado en 2015

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

artículo científico publicado en 2013

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2015

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab

artículo científico publicado en 2016

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival

artículo científico publicado en 2005

The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions

artículo científico publicado en 2004

The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas

artículo científico publicado en 2005

The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.

artículo científico publicado en 2006

The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with int

artículo científico publicado en 2003

The prognostic value of adaptive nuclear texture features from patient gray level entropy matrices in early stage ovarian cancer

artículo científico publicado el 1 de enero de 2012

The sexual activity questionnaire: pychometric properties and normative data in a norwegian population sample

artículo científico publicado en 2007

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients

artículo científico publicado en 2009

Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients

artículo científico publicado en 2005

X chromosome inactivation in cervical cancer patients

artículo científico publicado en 2003

beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients

artículo científico publicado en 2005

miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer

artículo científico publicado en 2022